Holen Sie sich die Stockscreener-App
29.79
1.22%
0.40
Schlusskurs vom Vortag:
$29.39
Offen:
$29.19
24-Stunden-Volumen:
129.61K
Relative Volume:
0.35
Marktkapitalisierung:
$944.35M
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
25.03
EPS:
1.19
Netto-Cashflow:
$274.29M
1W Leistung:
-0.70%
1M Leistung:
+2.41%
6M Leistung:
-24.13%
1J Leistung:
-22.53%
1-Tages-Spanne:
$29.12
$29.88
1-Wochen-Bereich:
$29.00
$30.52
52-Wochen-Spanne:
$27.27
$42.29
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Vergleichen Sie COLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
29.78 | 944.35M | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
163.26 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.96 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.15 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.32 | 17.38B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.87 | 14.05B | 612.78M | -86.37M | -62.91M | -0.87 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | Needham | Hold → Buy |
| 2024-07-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-05-10 | Herabstufung | Needham | Buy → Hold |
| 2024-05-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-25 | Bestätigt | Needham | Buy |
| 2023-05-02 | Fortgesetzt | Jefferies | Buy |
| 2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-14 | Eingeleitet | BWS Financial | Sell |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-02-19 | Fortgesetzt | Jefferies | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-04-12 | Fortgesetzt | Janney | Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-02-07 | Bestätigt | Needham | Buy |
| 2017-12-05 | Bestätigt | Needham | Buy |
| 2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
| 2015-06-01 | Eingeleitet | Jefferies | Buy |
| 2015-06-01 | Eingeleitet | Needham | Buy |
| 2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack - The Globe and Mail
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
Exclusive: Collegium Leaders Set for Key Investor Presentation at Needham Conference - Stock Titan
Analysts Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) PT at $43.60 - Defense World
HighTower Advisors LLC Has $428,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Raymond James Financial Inc. Makes New Investment in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Swiss National Bank Has $1.81 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
HC Wainwright Has Optimistic Outlook of COLL Q3 Earnings - Defense World
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting - GlobeNewswire
Q1 EPS Estimate for Collegium Pharmaceutical Cut by Analyst - Defense World
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board - Yahoo Finance
Collegium Pharmaceutical (NASDAQ:COLL) Receives “Buy” Rating from HC Wainwright - Defense World
Collegium pharmaceutical CFO Colleen Tupper sells shares for $228,250 By Investing.com - Investing.com South Africa
Collegium Pharmaceutical EVP sells shares worth $624,794 - Investing.com India
Collegium Pharmaceutical EVP sells shares worth $624,794 By Investing.com - Investing.com Australia
Collegium pharmaceutical CFO Colleen Tupper sells shares for $228,250 - Investing.com India
Forecasting The Future: 4 Analyst Projections For Collegium Pharmaceutical - Benzinga
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Charles Schwab Investment Management Inc. - Defense World
Collegium Pharmaceutical chairman of the board to retire - MSN
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks - The Globe and Mail
Amundi Has $446,000 Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical EVP Scott Dreyer sells $67,661 in stock By Investing.com - Investing.com Australia
Glen Santangelo Reiterates Buy Rating on Collegium Pharmaceutical, Citing Undervalued Pain Portfolio and Strong Market Positioning - TipRanks
Collegium Pharmaceutical EVP Scott Dreyer sells $67,661 in stock - Investing.com India
Collegium pharmaceutical CFO sells $29,313 in stock - Investing.com
Collegium Pharmaceutical reshuffles board, adds executives By Investing.com - Investing.com Australia
Collegium Pharmaceutical announces board changes and new EVP By Investing.com - Investing.com Canada
Collegium announces updates to its board of directors, executive team - TipRanks
Collegium Announces Updates to its Board of Directors and Executive Leadership Team - citybiz
Collegium Pharmaceutical announces board changes and new EVP - Investing.com
Collegium Pharmaceutical reshuffles board, adds executives - Investing.com India
Collegium Pharmaceutical Appoints New Executive VP and General Counsel - TipRanks
Collegium Announces Updates To Its Board Of Directors And Executive Leadership Team - Marketscreener.com
Collegium's Founder Steps Down as Company Unveils Strategic Leadership Overhaul - StockTitan
Bank of New York Mellon Corp Has $7.24 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium pharmaceutical CFO sells shares worth $313,412 By Investing.com - Investing.com Australia
Collegium pharmaceutical EVP Scott Dreyer sells shares for $461,671 By Investing.com - Investing.com Australia
Collegium pharmaceutical CFO sells shares worth $313,412 - Investing.com India
Collegium pharmaceutical EVP Scott Dreyer sells shares for $461,671 - Investing.com India
Have Collegium Pharmaceutical Insiders Been Selling Stock? - Simply Wall St
Collegium pharmaceutical EVP sells shares worth $169,299 By Investing.com - Investing.com South Africa
Collegium pharmaceutical CFO sells shares worth $103,591 - Investing.com India
Collegium pharmaceutical CFO sells shares worth $103,591 By Investing.com - Investing.com Canada
Collegium Announces Poster Presentations at the 2025 - GlobeNewswire
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care - GlobeNewswire Inc.
Collegium Pharmaceutical Executives Sell Shares - TradingView
Collegium pharmaceutical EVP sells shares worth $169,299 - Investing.com
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Collegium Pharmaceutical Inc-Aktie (COLL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tupper Colleen | EVP & Chief Financial Officer |
Mar 20 '25 |
Sale |
30.00 |
1,206 |
36,181 |
163,063 |
| Dreyer Scott | EVP & Chief Commercial Officer |
Mar 21 '25 |
Sale |
30.03 |
18,881 |
566,983 |
103,613 |
| Dreyer Scott | EVP & Chief Commercial Officer |
Mar 20 '25 |
Sale |
30.00 |
1,927 |
57,811 |
122,494 |
0.09%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):